Ronald Kirk Huntsman - Nov 26, 2024 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Signature
/s/ Bradford K. Amman as attorney-in-fact for Ronald Kirk Huntsman
Stock symbol
VVOS
Transactions as of
Nov 26, 2024
Transactions value $
$832,711
Form type
4
Date filed
11/27/2024, 04:47 PM
Previous filing
Jun 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VVOS Common Stock 3.46K Nov 26, 2024 Direct
holding VVOS Common Stock 69.6K Nov 26, 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $833K +315K +639.36% $2.64 365K Nov 26, 2024 Common Stock 315K $2.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Coronado V Partners, LLC, of which the Reporting Person is a member and manager.
F2 On September 7, 2024 (the "Grant Date"), the Reporting Person received a grant of 315,421 stock options, which grant was made under but subject to stockholder approval of the Issuer's 2024 Omnibus Equity Incentive Plan and such grant at the Issuer's 2024 Annual Meeting. Such meeting was held, and such stockholder approval was obtained, on November 26, 2024. One-third shall vest and become exercisable in three installments on each of the first, second and third anniversaries of the date of grant through September 7, 2027.